HCA Healthcare, Inc.

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong Margins
  • Robust Cash Flow
  • Heavy Debt

AI
AI Summary

6.0

HCA is no longer just a defensive hospital compounder; the investment case now hinges on whether its strong cash generation can offset reimbursement mix pressure, labor inflation, and leverage, making margin protection and sustained free cash flow the key proof points for upside.

CashFlow
ReimbursementRisk
Margins‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Strong Margins
  • Robust Cash Flow
  • Heavy Debt

HCA delivers strong cash generation and solid margins with reasonable valuation, but elevated leverage, negative working capital, and a weak balance sheet keep the investment case dependent on steady operating performance.

CashFlow
Leverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Strong rebound
  • Momentum cooling
  • Range breakout needed

HCA is still constructive over the last month after a sharp rebound, but momentum has cooled and it now needs to hold $400-$396 and clear $414-$418 to confirm the next leg up.

bullish
neutral
Support Level: $400-$396
Resistance Level: $414-$418

Sharp rebound from $371.18 to $418.19 was followed by a mild pullback

Sentiment & News

6.0

Key News Insights:

  • Shareholder probes
  • Q2 earnings beat
  • Guidance trimmed

HCA faced a growing overhang from shareholder investigations and class-action notices even as Q2 revenue and EPS beat expectations, but trimmed 2026 guidance and higher costs tempered the earnings strength. క

Earnings

HCA is likely to remain volatile near term as legal scrutiny and a softer outlook offset solid operating performance